Can you prescribe the discharge summary of Bronchial asthama
Reading File
Finding Sources
Searching the Web
bronchial asthma discharge summary template clinical
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Now I have enough clinical information to write a thorough, well-structured discharge summary. Let me compile it.
Discharge Summary - Bronchial Asthma (Acute Exacerbation)
Below is a standard clinical discharge summary template filled in for a typical bronchial asthma admission. You can adapt the patient-specific fields to your actual case.
DISCHARGE SUMMARY
Hospital Name: _______________________________
Department: Respiratory Medicine / General Medicine / Emergency Medicine
PATIENT DETAILS
| Field | Details |
|---|---|
| Patient Name | Mr./Ms. ______________ |
| Age / Sex | ___ years / M / F |
| IP Number | ___________ |
| Date of Admission | ___________ |
| Date of Discharge | ___________ |
| Total Duration of Stay | ___ days |
| Treating Physician | Dr. ______________ |
| Ward / Bed No. | ___________ |
DIAGNOSIS
Primary Diagnosis: Bronchial Asthma - Acute Exacerbation (Moderate / Severe)
Secondary Diagnosis / Comorbidities: (e.g., Allergic Rhinitis, GERD, Obesity - if applicable)
PRESENTING COMPLAINTS (on admission)
- Sudden onset breathlessness for ___ hours/days
- Wheezing
- Cough (dry / with mucoid expectoration)
- Chest tightness
- Inability to complete sentences (in severe cases)
HISTORY
- Past History: Known case of bronchial asthma since ___ years; previous admissions/ED visits - ____
- Trigger identified: Viral URTI / Allergen exposure / Exercise / Cold air / Stress / Unknown
- Smoking history: Never / Ex-smoker / Current smoker
- Drug history: Previously on ICS / SABA / LABA - compliance: good / poor
- Family history: Asthma / Atopy / Allergic rhinitis in ___
EXAMINATION ON ADMISSION
| Parameter | Value |
|---|---|
| General Condition | Dyspneic, anxious / distressed |
| BP | ___ / ___ mmHg |
| Pulse | ___ bpm (tachycardia) |
| Respiratory Rate | ___ breaths/min (tachypneic) |
| Temperature | Afebrile / Febrile |
| SpO2 | ___% on room air |
| Peak Expiratory Flow Rate (PEFR) | ___ L/min (___% predicted) |
| Auscultation | Bilateral wheeze, prolonged expiration, reduced air entry |
Severity on admission:
- Moderate exacerbation: SpO2 92-95%, PEFR 40-69% predicted, speaks in phrases
- Severe exacerbation: SpO2 <92%, PEFR <40% predicted, speaks in words/silent chest
INVESTIGATIONS
| Investigation | Result |
|---|---|
| ABG (if done) | pH ___, pCO2 ___, pO2 ___, HCO3 ___ |
| CBC | WBC ___, Hb ___, Eosinophils ___ |
| Chest X-Ray | Hyperinflation / no consolidation / normal |
| Serum IgE (if done) | ___ IU/mL |
| Sputum (if done) | Mucoid / Curschmann's spirals / eosinophils |
| Spirometry (baseline) | FEV1/FVC ___% (obstruction pattern) |
| ECG | Sinus tachycardia / normal |
| PEFR (on day 1 / discharge) | ___ / ___ L/min |
TREATMENT GIVEN DURING ADMISSION
1. Oxygen Therapy
- Supplemental O2 via face mask / nasal prongs to maintain SpO2 >95%
2. Bronchodilators
- Nebulized Salbutamol (Albuterol) 2.5 mg every 20 min x 3 doses (first hour), then every 1-4 hours
- Nebulized Ipratropium Bromide 0.5 mg every 20 min x 3 doses (first hour, especially in moderate-severe)
3. Corticosteroids
- IV Hydrocortisone 100-200 mg every 6 hours OR
- Oral/IV Prednisolone / Methylprednisolone 1 mg/kg/day
- Switched to Oral Prednisolone 40-60 mg/day as condition improved (5-7 day course)
4. Magnesium Sulfate (if severe/life-threatening)
- IV MgSO4 2 g over 20 minutes (single dose, given if inadequate response to initial therapy)
5. IV Fluids
- Maintenance IV fluids for hydration
6. Antibiotics (only if bacterial infection confirmed or strongly suspected)
- ______________ for ___ days
7. Monitoring
- Continuous SpO2 monitoring
- PEFR measured every 4-6 hours
- Respiratory rate and heart rate charting 4-hourly
- ABG repeated if SpO2 deteriorated
CLINICAL PROGRESS
| Day | PEFR (L/min / % predicted) | SpO2 | Treatment Change |
|---|---|---|---|
| Day 1 | ___ (___%) | ___% | Nebulization q20 min x 3, then q4h |
| Day 2 | ___ (___%) | ___% | Nebulization q6h, oral steroids |
| Day 3 | ___ (___%) | ___% | Stepped down to MDI, oral steroids |
| Discharge | ___ (>70%) | >95% | MDI + steroid course |
CONDITION AT DISCHARGE
- Patient comfortable, no dyspnea at rest
- Minimal/no wheeze on auscultation
- SpO2 ___% on room air
- PEFR ___ L/min (>70% of personal best or predicted)
- Tolerating oral medications well
DISCHARGE CRITERIA MET
Per standard guidelines (NAEPP/GINA), discharge is appropriate when:
- PEFR or FEV1 is >70% of predicted or personal best
- SpO2 >95% on room air
- Symptoms minimal and patient able to walk without dyspnea
- Adequate response to bronchodilator maintained for at least 1 hour
- Patient/family understands inhaler technique and action plan
DISCHARGE MEDICATIONS
| Medication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Salbutamol MDI (Reliever) | 100 mcg/puff, 1-2 puffs | Inhaled | As needed (every 4-6 hrs PRN) | Ongoing |
| Budesonide MDI / Fluticasone MDI (Controller - ICS) | 200-400 mcg/day | Inhaled | Twice daily | Long-term |
| Prednisolone (oral taper) | 40 mg | Oral | Once daily in morning | 5-7 days (remainder of course) |
| Montelukast (if applicable) | 10 mg | Oral | Once daily at night | Per physician |
| LABA (Formoterol / Salmeterol) - if step 3+ | Per combination inhaler | Inhaled | Twice daily | Per physician |
ADVICE AT DISCHARGE
1. Medications
- Continue all prescribed inhalers regularly - do NOT stop controller (ICS) when feeling better
- Use reliever (Salbutamol) only when needed; if using more than 2 days/week, contact your doctor
2. Inhaler Technique
- Proper MDI technique demonstrated and confirmed (shake, exhale, inhale slowly, hold 10 seconds)
- Spacer device provided/recommended (especially for children)
3. Trigger Avoidance
- Avoid known triggers: dust, smoke, pollens, pets, cold air, strong odors, viral infections
- Stop smoking (if applicable); avoid passive smoking
4. Peak Flow Monitoring (if available)
- Measure PEFR morning and evening, record in diary
- Green zone: >80% personal best - continue usual treatment
- Yellow zone: 50-80% - increase reliever, start oral steroids, call doctor
- Red zone: <50% - take reliever immediately, seek emergency care
5. Written Asthma Action Plan provided: Yes / No
6. Diet and Lifestyle
- Maintain healthy weight
- Regular exercise is encouraged (pre-treat with SABA before exercise if required)
- Adequate hydration
7. Warning signs - Return to Emergency immediately if:
- Rapid worsening of breathing not relieved by reliever inhaler
- PEFR <50% of personal best
- SpO2 <90%, blue lips or fingernails (cyanosis)
- Unable to speak in complete sentences
- Inability to walk due to breathlessness
FOLLOW-UP
- GP / Primary Care Physician: Within 1 week of discharge
- Respiratory/Pulmonology Specialist: Within 4-6 weeks (or sooner if symptoms worsen)
- Bring: Medications, peak flow diary, this discharge summary
PROGNOSIS
- Good with regular controller therapy, trigger avoidance, and adherence to action plan
- Risk of recurrence if triggers not managed or controller therapy discontinued
- Referral to allergy/immunology if allergic triggers identified
PHYSICIAN SIGNATURE
Signature: __________________
Name: Dr. __________________
Designation: __________________
Date: __________________
Sources used: Tintinalli's Emergency Medicine (9th ed.), NHLBI Asthma Care Quick Reference (NAEPP EPR-3 guidelines), and GINA discharge criteria.
Note: This is a clinical template for educational and documentation purposes. All patient-specific fields (marked with blanks) must be filled in by the treating physician with the actual patient data. Medication doses should be verified against current formulary and individualized to the patient's age, weight, and comorbidities.
This is a shared conversation. Sign in to Orris to start your own chat.